Primary Ciliary Dyskinesia CRISPR Knockout Cell Models for Research

Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous autosomal recessive disorder with an estimated incidence of 1 in 15,000 to 1 in 30,000 live births worldwide (WHO, 2023). The disease is characterized by impaired mucociliary clearance due to defective ciliary structure and function, leading to chronic respiratory tract infections, bronchiectasis, sinusitis, and infertility. Approximately 50% of patients exhibit situs inversus totalis (Kartagener syndrome). Diagnosis is often delayed due to symptom overlap with other respiratory diseases, and no curative therapies exist. The 5-year survival is near normal with aggressive management, but quality of life is significantly reduced due to progressive lung damage (NCI, 2023).

PCD is an ideal model for studying ciliary biology, mucociliary clearance, and genotype-phenotype correlations. Over 50 causative genes have been identified, many encoding components of the dynein arm, radial spokes, or central apparatus. Public datasets from the NCBI Gene database and ClinVar provide extensive mutation data. Key open questions include the functional impact of specific variants, mechanisms of ciliary assembly, and development of targeted therapies. Gene-edited cell models enable precise dissection of these mechanisms.

PCD results from defects in motile cilia structure and function. The major pathways include:

• • Outer dynein arm (ODA) assembly: Defects in DNAH5, DNAI1, DNAI2 disrupt microtubule sliding and ciliary beat frequency.
• • Inner dynein arm (IDA) assembly: Mutations in CCDC39, CCDC40, DYX1C1 cause abnormal waveform.
• • Radial spoke and central apparatus: Defects in RSPH1, RSPH4A, RSPH9, HYDIN impair ciliary beat coordination.
• • Cytoplasmic preassembly factors: Mutations in LRRC6, ZMYND10, SPAG1 block dynein arm transport to the cilium.

Data from NCBI Gene, ClinVar, and COSMIC (2024).

Ciliary dysfunction in PCD affects multiple signaling pathways:

• • Hedgehog signaling: Cilia are essential for Shh signal transduction; defects impair Gli transcription factor processing.
• • Wnt signaling: Ciliary proteins modulate beta-catenin and planar cell polarity pathways.
• • Calcium signaling: Ciliary beat frequency is regulated by intracellular calcium levels via mechanosensitive channels.
• • Inflammatory signaling: Chronic airway inflammation activates NF-kB and IL-8 pathways, leading to neutrophil recruitment and tissue damage.

Air-liquid interface (ALI) cultures of primary cells and organoids recapitulate mucociliary differentiation, enabling functional assays such as ciliary beat frequency measurement and particle transport.

Animal models for PCD include:

• • Dnah5 knockout mouse: Recapitulates ODA defects, chronic sinusitis, and hydrocephalus.
• • Dnai1 knockout mouse: Shows reduced ciliary beat frequency and airway inflammation.
• • Ccdc39 mutant mouse: Displays IDA defects and situs inversus.
• • Zebrafish morphants: Used for high-throughput screening of ciliary motility and laterality defects.
• • Xenopus embryos: Allow visualization of ciliary flow and multiciliated cell differentiation.

CRISPR-Cas9 gene editing enables the creation of isogenic cell lines with precise PCD mutations. Examples include:

• • DNAH5 knockout in BEAS-2B or hTERT-RPE1 cells: Recapitulates ODA loss and immotile cilia.
• • DNAI1 knockout in 16HBE14o- cells: Models reduced ciliary beat frequency.
• • CCDC39 knockout in primary nasal epithelial cells: Induces IDA defects and abnormal waveform.
• • LRRC6 knockout in hTERT-RPE1: Blocks dynein arm assembly, causing complete ciliary immotility.

Commercially available, sequence-verified models accelerate research by providing reproducible, isogenic backgrounds for functional studies, drug screening, and mechanistic analysis. These models are available from commercial sources and can be customized for specific mutations.

Knockout and knock-in lines validate the role of candidate PCD genes. For example:

• • DNAH5 knockout in hTERT-RPE1 cells confirmed loss of ODA and reduced ciliary beat frequency, establishing causality.
• • CCDC39 knockout in BEAS-2B cells demonstrated IDA disorganization and abnormal waveform, linking genotype to phenotype.
• • Rescue experiments with wild-type cDNA restore ciliary function, confirming mutation specificity.

Isogenic pairs (wild-type vs. PCD mutant) enable high-throughput screening for compounds that improve ciliary function. Examples:

• • Screening for readthrough agents in nonsense mutation models (e.g., DNAH5 R2635X).
• • Testing small molecules that enhance dynein arm assembly or ciliogenesis.
• • Evaluating gene therapy vectors (e.g., AAV-mediated gene replacement) in knockout cell lines.

CRISPR-based screens identify synthetic lethal partners or modifiers of ciliary dysfunction. For example:

• • Genome-wide CRISPR knockout screens in DNAH5-deficient cells identify genes whose loss restores ciliary motility.
• • Targeted screens for modulators of ciliary beat frequency reveal new therapeutic targets.
• • Proteomic analysis of isogenic lines identifies biomarkers for PCD diagnosis and progression.